2-38675916-C-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_138801.3(GALM):c.195C>A(p.Tyr65*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,613,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00013 ( 0 hom. )
Consequence
GALM
NM_138801.3 stop_gained
NM_138801.3 stop_gained
Scores
2
2
3
Clinical Significance
Conservation
PhyloP100: 0.185
Genes affected
GALM (HGNC:24063): (galactose mutarotase) This gene encodes an enzyme that catalyzes the epimerization of hexose sugars such as glucose and galactose. The encoded protein is expressed in the cytoplasm and has a preference for galactose. The encoded protein may be required for normal galactose metabolism by maintaining the equilibrium of alpha and beta anomers of galactose.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-38675916-C-A is Pathogenic according to our data. Variant chr2-38675916-C-A is described in ClinVar as [Pathogenic]. Clinvar id is 2414354.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALM | NM_138801.3 | c.195C>A | p.Tyr65* | stop_gained | 2/7 | ENST00000272252.10 | NP_620156.1 | |
GALM | XM_011532540.3 | c.195C>A | p.Tyr65* | stop_gained | 2/6 | XP_011530842.1 | ||
GALM | XM_047443419.1 | c.195C>A | p.Tyr65* | stop_gained | 2/6 | XP_047299375.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALM | ENST00000272252.10 | c.195C>A | p.Tyr65* | stop_gained | 2/7 | 1 | NM_138801.3 | ENSP00000272252.5 | ||
GALM | ENST00000410063.5 | c.190+9565C>A | intron_variant | 3 | ENSP00000386233.1 | |||||
GALM | ENST00000427858.4 | n.276C>A | non_coding_transcript_exon_variant | 2/4 | 4 | |||||
GALM | ENST00000444351.5 | n.114C>A | non_coding_transcript_exon_variant | 2/7 | 5 | ENSP00000409083.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 151980Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
8
AN:
151980
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251454Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135896
GnomAD3 exomes
AF:
AC:
12
AN:
251454
Hom.:
AF XY:
AC XY:
5
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000130 AC: 190AN: 1461818Hom.: 0 Cov.: 31 AF XY: 0.000113 AC XY: 82AN XY: 727216
GnomAD4 exome
AF:
AC:
190
AN:
1461818
Hom.:
Cov.:
31
AF XY:
AC XY:
82
AN XY:
727216
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000526 AC: 8AN: 151980Hom.: 0 Cov.: 31 AF XY: 0.0000539 AC XY: 4AN XY: 74224
GnomAD4 genome
AF:
AC:
8
AN:
151980
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
74224
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
5
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 27, 2022 | For these reasons, this variant has been classified as Pathogenic. Studies have shown that this premature translational stop signal alters GALM gene expression (PMID: 30910422). This variant has not been reported in the literature in individuals affected with GALM-related conditions. This variant is present in population databases (rs367911059, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Tyr65*) in the GALM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GALM are known to be pathogenic (PMID: 30451973). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
N
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at